Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118462) titled 'HighCycle Study: Acetazolamide, High Altitude and Plasma Volume' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Centre d'Expertise sur l'Altitude EXALT
Condition:
High Altitude Effects
High Altitude Hypoxia
Acute Mountain Sickness (AMS)
Plasma Volume
Women
Intervention:
Drug: Acetazolamide
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: July 15, 2024
Target Sample Size: 270
Countri...